CLINICAL_TRIALS
trial_result
· 2019-04-02
Clinical Trial Update: A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia [Phase 1]
Summary
Phase I multicenter dose-escalation study in patients with Hairy Cell Leukemia completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: MedImmune LLC | Conditions: Hairy Cell Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2019-04-02